Cargando…
Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study: reply
Autores principales: | Nakaoka, Yoshikazu, Yamashita, Katsuhisa, Yamakido, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449802/ https://www.ncbi.nlm.nih.gov/pubmed/32594147 http://dx.doi.org/10.1093/rheumatology/keaa255 |
Ejemplares similares
-
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study
por: Nakaoka, Yoshikazu, et al.
Publicado: (2020) -
Vascular imaging of patients with refractory Takayasu arteritis treated with tocilizumab: post hoc analysis of a randomized controlled trial
por: Nakaoka, Yoshikazu, et al.
Publicado: (2021) -
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
por: Nakaoka, Yoshikazu, et al.
Publicado: (2018) -
Reply to ‘Comment on “Coherent control in the extreme ultraviolet and attosecond regime by synchrotron radiation”’
por: Hikosaka, Y., et al.
Publicado: (2021) -
Reply To: Comments on identifying causal relationships in nonlinear dynamical systems via empirical mode decomposition
por: Yang, Albert C., et al.
Publicado: (2022)